Skip to content

Study · Case report or series · n = 1 · 1991

1 result

[Local administration of cerebrolysin in Raynaud's disease in a 2-year-old child].

Osipenko TN, Skvortsov IA, Korshunov SV

Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)1 Jan 1991

PMID1661499 (opens in a new tab)PepBankPUB-01661499
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a child with Raynaud's disease, local metameric cerebrolysin application successfully counteracted the main clinical manifestations.

    In plain wordsIn a child with Raynaud's disease, local cerebrolysin treatment successfully counteracted the main symptoms.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseRaynaud's clinical manifestations
    Study

    n = 1

    Outcome group
    Vascular function · Cardiovascular
    Studied dose
    Dose not stated · local metameric application (neuromeric, scleromeric puncturing)As given in this study (human).

    Source sentences

    Summary
    The case is characterized by successful counteracting the main clinical manifestations of Raynaud's phenomenon by the local metameric application of cerebrolysin (neuromeric, scleromeric puncturing) employed by the authors for the first time for the disease treatment.
    1 context sentence
    Summary · context
    A case of Raynaud's disease in a 2-year-old child seen by the authors for 1.5 yr. is described.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.